You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股通龍虎榜 | 北水繼續加碼小米
uSMART友信智投 09-16 18:26

北水總結

9月16日港股市場,北水淨流入18.5億,其中港股通(滬)淨流入6.74額億,港股通(深)淨流入額11.76億。

北水淨買入最多的個股是小米集團、美團點評、信達生物,北水淨賣出最多的個股是中國飛鶴、中芯國際。

十大成交活躍股

個股點評

小米集團獲淨買入3.27億港元。小米集團副董事長售3.5億B類股,林斌剩餘股份會鎖定五年證券市場分析認爲,這麼長的鎖定期限較爲罕見,顯示出林斌對公司長遠發展的信心。

美團點評獲淨買入3.05億港元,華創證券稱,衛生事件爲本地生活賽道帶來極大的機會。我們認爲公司有望成長爲後衛生事件時代服務業線上化的無邊界巨頭,看好公司長期港股核心資產龍頭地位。維持目標價285 港元,評級“推薦”。

信達生物獲淨買入1.95億港元。信達生物和禮來製藥將於9月19日至21日的2020年歐洲腫瘤內科學會(ESMO)年會上,共同宣佈六項關於達伯舒(信迪利單抗注射液)的最新臨牀研究成果。

海底撈獲淨買入9375萬港元。值得注意的是,該股暫現六連陽,累計漲幅超16%,盤中以60.3港元再創新高。

當日港股通淨買入和淨賣出排行榜(億港元)

(港股通持股比例排行,交易所的數據T+2日結算)

 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account